These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15285409)

  • 1. [Clarithromycin: specific features of antimicrobial spectrum and clinical use].
    Budanov SV; Vasil'ev AN
    Antibiot Khimioter; 2004; 49(2):19-25. PubMed ID: 15285409
    [No Abstract]   [Full Text] [Related]  

  • 2. The newer macrolides: azithromycin and clarithromycin.
    Zuckerman JM
    Infect Dis Clin North Am; 2000 Jun; 14(2):449-62, x. PubMed ID: 10829265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of antimicrobial agents used for the management of CARTIs: a focus on a new class of antimicrobials--the ketolides.
    Sbarbaro JA
    Am J Manag Care; 2004 Oct; 10(12 Suppl):S389-99. PubMed ID: 15603248
    [No Abstract]   [Full Text] [Related]  

  • 4. [New semisynthetic macrolides. Clarithromycin--its importance in the current therapy of bacterial infections].
    Iakovlev VP
    Antibiot Khimioter; 1999; 44(10):22-7. PubMed ID: 10635418
    [No Abstract]   [Full Text] [Related]  

  • 5. [Azithromycin (sumamed)--in the treatment of respiratory tract infections].
    Fomina IP; Smirnova LB; Iudin SM
    Antibiot Khimioter; 1996 Feb; 41(2):52-61. PubMed ID: 8929121
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimicrobial screening of Nicotiana tobacum on organisms isolated from patients with respiratory tract infection.
    Adeleye IA; Uwagboe UC
    West Indian Med J; 2003 Dec; 52(4):325-6. PubMed ID: 15040073
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical implications of macrolide resistance in community-acquired respiratory tract infections.
    Hoban DJ; Zhanel GG
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):973-80. PubMed ID: 17181414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clarithromycin (klaricid, Abbott).
    MacConnachie AM
    Intensive Crit Care Nurs; 1996 Feb; 12(1):60-1. PubMed ID: 8696027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative potencies of azithromycin, clarithromycin and five other orally administered antibiotics.
    Barry AL; Fuchs PC; Brown SD
    J Antimicrob Chemother; 1995 Apr; 35(4):552-5. PubMed ID: 7628991
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversibility of antimicrobial resistance in respiratory isolates in HIV-positive Cambodian children after 36 months of HAART.
    Shahum A; Benca G; Duong LS; Augustin A; Havlik S; Liska A; Kalavsky E; Beno P; Krcmery V
    J Antimicrob Chemother; 2007 Jul; 60(1):194-7. PubMed ID: 17545143
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathogens resistant to antibacterial agents.
    Chen LF; Chopra T; Kaye KS
    Infect Dis Clin North Am; 2009 Dec; 23(4):817-45, vii. PubMed ID: 19909886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010.
    Wang H; Chen M; Xu Y; Sun H; Yang Q; Hu Y; Cao B; Chu Y; Liu Y; Zhang R; Yu Y; Sun Z; Zhuo C; Ni Y; Hu B; Tan TY; Hsueh PR; Wang JH; Ko WC; Chen YH; Wahjono H
    Int J Antimicrob Agents; 2011 Nov; 38(5):376-83. PubMed ID: 21880469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of antimicrobial drug resistance in respiratory tract pathogens, isolated in a northern Italian teaching hospital between 1990 and 1999.
    Ferrara A; Morosini M; Dos Santos C; Fietta A
    J Chemother; 2002 Dec; 14(6):568-73. PubMed ID: 12583547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of moxifloxacin on bacterial pathogenicity factors in comparison with amoxicillin, clarithromycin and ceftriaxone.
    Drago L; De Vecchi E; Nicola L; Tocalli L; Gismondo MR
    J Chemother; 2004 Feb; 16(1):30-7. PubMed ID: 15077996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of antimicrobial resistance pattern of selected respiratory tract pathogens isolated from different animal species].
    Wettstein K; Frey J
    Schweiz Arch Tierheilkd; 2004 Sep; 146(9):417-22. PubMed ID: 15481587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance.
    Lee SY; Kuti JL; Nicolau DP
    Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of antibiotic resistance and resistance mechanisms. Foreword.
    Bonomo RA; Rossolini GM
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):549-50. PubMed ID: 18847392
    [No Abstract]   [Full Text] [Related]  

  • 19. The newer macrolides. Azithromycin and clarithromycin.
    Zuckerman JM; Kaye KM
    Infect Dis Clin North Am; 1995 Sep; 9(3):731-45. PubMed ID: 7490441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New antibiotics for severe sepsis--the break-through?].
    Burgmann H
    Dtsch Med Wochenschr; 2008 Feb; 133(8):372-3. PubMed ID: 18270921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.